Afshin Dowlati, MD

From Bench to Bedside: Non-Small Cell Lung Cancer Discovery Creates Hope

Afshin Dowlati, MD describes how his team of researchers discovered a new non-small cell lung cancer subtype in the laboratory and brought a new treatment for this cancer subtype to patients in a clinical trial.

6/15/2023 By Daniel Simon, MD and Afshin Dowlati, MD

Phase 1 Clinical Trials Program at UH Seidman Cancer Center is a Leader in the Field

Investigatory Excellence - Innovations in Cancer | Fall 2019

11/3/2019 By Afshin Dowlati, MD and UH

Genomics for the Next Generation

New approach at UH Seidman Cancer Center simplifies testing, integrates genomics information with other complex tests Innovations in Cancer - Winter 2016 Download PDF Joseph Willis, MD Christopher Hoimes, MD Afshin Dowlati, MD ...

1/1/2016 By Joseph Willis, MD, Christopher Hoimes, DO, Afshin Dowlati, MD, and Shaveta Vinayak, MD

Schedule an appointment today

From Bench to Bedside: Non-Small Cell Lung Cancer Discovery Creates Hope

Phase 1 Clinical Trials Program at UH Seidman Cancer Center is a Leader in the Field

Genomics for the Next Generation

Stay connected to your care.